Pfizer (PFE) Stock on December 6, 2025: Metsera Deal, 2025 Guidance and What Wall Street Expects Next
Pfizer Inc. (NYSE: PFE) is ending 2025 in better shape than it started, but investors are still debating whether the stock is a high‑yield value opportunity or a classic “value trap.” As of Friday, December 5, 2025, Pfizer shares closed at $26.03, up 1.28% on the day and marking a third straight session of gains. The stock sits about 6% below its 52‑week high of $27.69 (hit on October 3) and roughly 24% above its April low of $20.92.MarketWatch+1 At the same time, Pfizer offers an unusually rich dividend yield of about 6.6%, a fortress‑like balance sheet for a big